It's not at all recognised if REXULTI is Protected and successful in children under 13 a long time of age with schizophrenia.Ketamine use has also been expanded to nonanalgesic uses as well. The United States Food and Drug Affiliation approved intranasal ketamine to deal with resistant unipolar depression and suicidal ideations. Ketamine has also b